Evidence map›Paper›PMID 29111538›Full record

Trial reportAsian journal of andrology

Hormone levels following surgical and medical castration: defining optimal androgen suppression.

Michael T Schweizer, Michael L Hancock, Robert H Getzenberg, Evan Y Yu

Abstract readLetterRandomized Controlled Trial
In one paragraph

Trial report in Asian journal of andrology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michael T SchweizerDivision of Oncology, Department of Medicine, University of Washington, Seattle, WA 98116, USA.
Michael L HancockDivision of Oncology, Department of Medicine, University of Washington, Seattle, WA 98116, USA Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98116, USA Veru Healthcare, Miami, FL 33137, USA.
Robert H GetzenbergVeru Healthcare, Miami, FL 33137, USA.
Evan Y YuDivision of Oncology, Department of Medicine, University of Washington, Seattle, WA 98116, USA.

Funding

TRANSCRIPTOME AND PROTEOME STRATIFICATION OF PROSTATE ADENOCARCINOMA PHENOTYPESP50CA097186 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETER S NELSON · 2002 to 2026
$58.1M
NCI NIH HHS P50 CA097186
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

OrchiectomyAgedAged, 80 and overAndrogen AntagonistsAndrogensCohort StudiesGonadotropin-Releasing HormoneHormonesHumansLuteinizing HormoneMaleMiddle AgedProstatic NeoplasmsToremifeneAndrogen AntagonistsAndrogensGonadotropin-Releasing HormoneHormonesLuteinizing HormoneToremifene

Identifiers

PMID29111538
PMCPMC6038162

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.